We have received text from H.R. 9364: Facilitating Access to Service and Timely Repairs for Wheelchairs Act. This bill was received on 2026-06-18, and currently has 13 cosponsors.

Here is a short summary of the bill:

This bill would change how Medicare Advantage plans handle repairs for certain wheelchairs and related equipment.

What it would do

For complex rehabilitation technology —which includes certain power wheelchairs, manual wheelchairs, and related accessories—the bill would stop Medicare Advantage plans from requiring:

• prior authorization before a repair can be covered,
• a prescription specifically for the repair, or
• extra medical documentation just to approve the repair.

When the change would apply

The new rule would apply to plan years starting on or after January 1 following enactment . In other words, the change would not take effect immediately, but beginning with the next plan year after the bill becomes law.

What would still be allowed

The bill says Medicare Advantage plans could still use prior authorization for:

• the initial evaluation of whether the wheelchair or related equipment is medically necessary, and
• replacement of the equipment if it is lost, permanently damaged, reaches its reasonable useful lifetime, or has been in use for 5 years .

What counts as complex rehabilitation technology

The bill defines this to include:

• certain complex rehabilitative power wheelchairs ,
• certain complex rehabilitative manual wheelchairs ,
• certain other manual wheelchairs , and
• related accessories used with those devices.

Plain-language summary

In practical terms, the bill is meant to make it easier and faster for people enrolled in Medicare Advantage to get repairs for certain medically necessary wheelchairs and related equipment, by removing plan-level approval hurdles for those repairs.

Relevant Companies

• CMS — Medicare Advantage plans would have to follow the new repair-coverage rules, which could affect plan administration and utilization review processes.
• HUM — As a major Medicare Advantage insurer, it could need to change prior authorization and claims processes for wheelchair repairs.
• UNH — Its Medicare Advantage business could be affected by limits on prior authorization for certain durable medical equipment repairs.
• CNC — If its Medicare Advantage plans cover these services, it may need to adjust repair approval procedures.
• ELV — Its Medicare Advantage operations could face changes in how repairs for covered wheelchairs are reviewed and approved.

Representative Ayanna Pressley Bill Proposals

Here are some bills which have recently been proposed by Representative Ayanna Pressley:

• H.R.9364: FAST Repairs for Wheelchairs Act
• H.R.8940: Federal Death Penalty Prohibition Act
• H.R.8903: Renter Resource Center Act
• H.R.8829: Reproductive Health Care Accessibility Act
• H.R.8588: Housing FIRST Act
• H.R.8235: Books Save Lives Act

You can track bills proposed by Representative Ayanna Pressley on Quiver Quantitative's politician page for Pressley.

Representative Ayanna Pressley Net Worth

Quiver Quantitative estimates that Representative Ayanna Pressley is worth $4.9M, as of June 19th, 2026. This is the 170th highest net worth in Congress, per our live estimates.

Pressley has approximately $0 invested in publicly traded assets which Quiver is able to track live.

You can track Representative Ayanna Pressley's net worth on Quiver Quantitative's politician page for Pressley.

2026 Massachusetts's 7th Congressional District Election

There has been approximately $1,510,769 of spending in Massachusetts's 7th congressional district elections over the last two years, per our estimates.

Approximately $25,509 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:

• WE DECIDE ($23,504)
• CHINESE PROGRESSIVE POLITICAL ACTION INC. ($1,610)

The rating for this race is currently "Solid D".

You can track this election on our matchup page for the 2026 Massachusetts's 7th congressional district election.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read full article here »